BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17869107)

  • 1. Radiolabelled somatostatin analogs for diagnosis and radio-guided surgery of neuroendocrine breast cancer undetectable with conventional imaging procedures.
    Panareo S; Carcoforo P; Lanzara S; Corcione S; Bagatin E; Casali M; Costanzo A; Basaglia E; Feggi LM
    Breast; 2008 Feb; 17(1):111-4. PubMed ID: 17869107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
    Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
    Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
    Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
    J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of (99m)Tc-tetrofosmin pinhole-SPECT in breast cancer non palpable axillary lymph node metastases detection.
    Spanu A; Tanda F; Dettori G; Manca A; Chessa F; Porcu A; Falchi A; Nuvoli S; Madeddu G
    Q J Nucl Med; 2003 Jun; 47(2):116-28. PubMed ID: 12865872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
    Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
    J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
    Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
    Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
    Crossin JA; Johnson AC; Stewart PB; Turner WW
    Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors.
    Schillaci O; Spanu A; Scopinaro F; Falchi A; Corleto V; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
    Int J Oncol; 2003 Dec; 23(6):1687-95. PubMed ID: 14612942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m-MIBI scintimammography by planar and SPECT imaging in the diagnosis of breast carcinoma and axillary lymph node involvement.
    Myslivecek M; Koranda P; Kamínek M; Husák V; Hartlová M; Dusková M; Cwiertka K
    Nucl Med Rev Cent East Eur; 2004; 7(2):151-5. PubMed ID: 15968602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement.
    de Kanter AY; Menke-Pluijmers MB; Henzen-Logmans SC; van Geel AN; van Eijck CJ; Wiggers T; Eggermont AM
    Eur J Surg Oncol; 2006 Jun; 32(5):498-501. PubMed ID: 16580810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary node metastasis detection in breast cancer with 99mTc-sestaMIBI and 111In-pentetreotide.
    Chiti A; Maffioli LS; Agresti R; Spinelli A; Savelli G; Casteliani MR; Giovanazzi R; Greco M; Bombardieri E
    Tumori; 1997; 83(2):537-8. PubMed ID: 9226013
    [No Abstract]   [Full Text] [Related]  

  • 14. Contribution of ¹¹¹In-pentetreotide SPECT/CT imaging to conventional somatostatin receptor scintigraphy in the detection of neuroendocrine tumours.
    Sainz-Esteban A; Olmos R; González-Sagrado M; González ML; Ruiz MÁ; García-Talavera P; Gamazo C; Villanueva JG; Cobo A; de Luis D
    Nucl Med Commun; 2015 Mar; 36(3):251-9. PubMed ID: 25369750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radio-guided sentinel lymph node biopsy using periareolar injection technique for patients with early breast cancer.
    Yen RF; Kuo WH; Lien HC; Chen TH; Jan IS; Wu YW; Wang MY; Chang KJ; Huang CS
    J Formos Med Assoc; 2007 Jan; 106(1):44-50. PubMed ID: 17282970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor scintigraphy of non-neuroendocrine cancers with In-111 pentetreotide.
    Limouris GS; Rassidakis A; Kondi-Paphiti A; Triantafyllou N; Manetou A; Gennatas K; Vitoratos N; Gregoriou O; Stavraka A; Vlahos L
    Hybridoma; 1997 Feb; 16(1):133-7. PubMed ID: 9085140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonimage-guided fine needle aspiration biopsy of palpable axillary lymph nodes in breast cancer patients.
    Marti JL; Ayo D; Levine P; Hernandez O; Rescigno J; Axelrod DM
    Breast J; 2012; 18(1):3-7. PubMed ID: 22098412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioguided surgery with radiolabeled somatostatin analogs: not only in GEP-NETs.
    Cuccurullo V; Di Stasio GD; Mansi L
    Nucl Med Rev Cent East Eur; 2017; 20(1):49-56. PubMed ID: 28218348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine tumor with an atypical clinical course: a description of 2 cases.
    Arrue I; Arregui MA; Catón B; Soloeta R
    Actas Dermosifiliogr; 2014; 105(1):94-6. PubMed ID: 23260877
    [No Abstract]   [Full Text] [Related]  

  • 20. Intraoperative gamma probe detection of neuroendocrine tumors.
    Adams S; Baum RP; Hertel A; Wenisch HJ; Staib-Sebler E; Herrmann G; Encke A; Hör G
    J Nucl Med; 1998 Jul; 39(7):1155-60. PubMed ID: 9669386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.